These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 26233933
1. Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes mellitus in the United Kingdom. Tunceli K, Iglay K, Zhao C, Brodovicz KG, Radican L. Diabetes Res Clin Pract; 2015 Sep; 109(3):e27-31. PubMed ID: 26233933 [Abstract] [Full Text] [Related]
2. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis. Adeyemi AO, Rascati KL, Lawson KA, Strassels SA. Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712 [Abstract] [Full Text] [Related]
3. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid. Oladapo AO, Barner JC, Rascati KL, Strassels SA. Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828 [Abstract] [Full Text] [Related]
4. Compliance and persistence with concomitant statin and oral antihyperglycemic therapy. Zhang Q, Zhao C, Davies MJ, Radican L, Seck T. Am J Manag Care; 2011 Nov; 17(11):746-52. PubMed ID: 22084894 [Abstract] [Full Text] [Related]
5. One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus: An observational study. Huber CA, Rapold R, Brüngger B, Reich O, Rosemann T. Medicine (Baltimore); 2016 Jun; 95(26):e3994. PubMed ID: 27368004 [Abstract] [Full Text] [Related]
6. Differences in health outcomes associated with initial adherence to oral antidiabetes medications among veterans with uncomplicated Type 2 diabetes: a 5-year survival analysis. Gatwood JD, Chisholm-Burns M, Davis R, Thomas F, Potukuchi P, Hung A, Kovesdy CP. Diabet Med; 2018 Nov; 35(11):1571-1579. PubMed ID: 29978496 [Abstract] [Full Text] [Related]
7. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Kirkman MS, Rowan-Martin MT, Levin R, Fonseca VA, Schmittdiel JA, Herman WH, Aubert RE. Diabetes Care; 2015 Apr; 38(4):604-9. PubMed ID: 25573883 [Abstract] [Full Text] [Related]
8. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database. Zhang Q, Rajagopalan S, Mavros P, Engel SS, Davies MJ, Yin D, Radican L. Curr Med Res Opin; 2010 Jul; 26(7):1697-703. PubMed ID: 20465367 [Abstract] [Full Text] [Related]
10. Missed doses of oral antihyperglycemic medications in US adults with type 2 diabetes mellitus: prevalence and self-reported reasons. Vietri JT, Wlodarczyk CS, Lorenzo R, Rajpathak S. Curr Med Res Opin; 2016 Sep; 32(9):1519-27. PubMed ID: 27144490 [Abstract] [Full Text] [Related]
11. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension. An J, Nichol MB. Med Care; 2013 Oct; 51(10):879-87. PubMed ID: 23929398 [Abstract] [Full Text] [Related]
19. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R. Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391 [Abstract] [Full Text] [Related]
20. Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a 4-year retrospective study from national primary care data. Mazzaglia G, Yurgin N, Boye KS, Trifirò G, Cottrell S, Allen E, Filippi A, Medea G, Cricelli C. Pharmacol Res; 2008 May; 57(5):358-63. PubMed ID: 18455425 [Abstract] [Full Text] [Related] Page: [Next] [New Search]